Skip to main content
Dana Roque, MD, Obstetrics & Gynecology, Baltimore, MD

DanaMarieRoqueMD

Obstetrics & Gynecology • Baltimore, MD

Gynecologic Oncology

Associate Professor, Gynecologic Oncology, University of Maryland-Greenebaum Cancer Center; Director, Center of Excellence in Minimally Invasive Gynecology

Join to view full profile

Dr. Roque is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Roque's full profile

Already have an account?

  • Office

    University of Maryland Medical Center
    22 S Greene St
    Baltimore, MD 21201
    Phone+1 410-328-2076
    Fax+1 410-328-8389

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Gynecologic Oncology, 2011 - 2014
  • UPMC Medical Education
    UPMC Medical EducationResidency, Obstetrics and Gynecology, 2007 - 2011
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 2007

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2014 - 2025
  • CT State Medical License
    CT State Medical License 2011 - 2015
  • PA State Medical License
    PA State Medical License 2007 - 2012
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • New Study Reveals a Two-Drug Combination to Fight Malignant Ovarian Cancer
    New Study Reveals a Two-Drug Combination to Fight Malignant Ovarian CancerFebruary 15th, 2022
  • Yale Cancer Center Led Research Shows New Drug Combination Effective for Patients with Advanced Ovarian Cancer
    Yale Cancer Center Led Research Shows New Drug Combination Effective for Patients with Advanced Ovarian CancerFebruary 14th, 2022
  • Combo Tx Active in Recurrent, Platinum-Resistant Ovarian Cancer
    Combo Tx Active in Recurrent, Platinum-Resistant Ovarian CancerMarch 26th, 2021

Dr. Dana Roque, Dr. Dana Roque, MD, Dr. D Roque, Dr. Dana Marie Roque